To study safety and efficacy of vascular closure devices following transfemoral PCI

PGIMER0 个研究点目标入组 100 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1)Patient with coronary artey disease i.e, chronic stable angina, unstable angina, non ST elevation MI, ST elevation MI suggested for PCI.
•2)Age more than 18 yrs.
•3)Patient who give consent

•1)Pregnant or lactating females.
•2)Clinically severe peripheral vascular disease in the ipsilateral limb,defined as severe claudication(walking <100 feet),weak or absent pulses,or lower extremity vascular graft.
•3)History of ipsilateral femoral or radial arterial puncture <3months prior to screening or history of vascular closure device deployment in ipsilateral femoral or radial artery at any time.
•4)Presence of clinically significant hematoma ,pseudoaneurysm or AV fistula prior to arterial closure
•5)Participation in a study of another coronary device; or inability to follow the protocol.
•6)Who did not give consent.

发起方